Home / Hydrochlorothiazide / United States
US ATC C03AA03 · updated 2 Nov 2026
Hydrochlorothiazide shortage in United States
Is there a Hydrochlorothiazide shortage in United States?
Yes. As of 2 Nov 2026, 2 Hydrochlorothiazide products are reported short in United States, the first since 19 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Microzide, Capsule, 12.5 mg (NDC 0591-0347-01) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Nov 2025 | not given | Not stated |
| US | Microzide, Capsule, 12.5 mg (NDC 0591-0347-05) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).